My watch list
my.bionity.com  
Login  
NEWS
Current news

How cells handle a sticky, toxic, but absolutely essential molecule

A new study shows that a protein known for its role in metabolism also helps deliver heme where it's needed

18-Sep-2018 Do you enjoy breathing air? You should spare a thought once in a while for heme, an iron-containing molecule essential to all organisms engaged in an air-breathing lifestyle. Heme molecules are most famously part of hemoglobin, the oxygen-transporting protein in blood, but they are also com ... more

TRIANNI & the German Society for Immunology (DGfI) honors outstanding young scientists.

18-Sep-2018 Every year, the German Society for Immunology awards two doctoral and three early-career prizes to young scientists who have made an outstanding contribution in the field of immunology. The award ceremony took place during the 5th European Congress of Immunology in Amsterdam. TRIANNI was ho ... more

BIA Separations Expands with New Upstream Processing Facility

Investment in new lab will support integrated optimisation of upstream and downstream process development

18-Sep-2018 BIA Separations announced the expansion of its services with the opening of a new upstream processing (USP) laboratory. The investment in the new facility comes in response to customer demand for services that optimise the critical interface between upstream and downstream processing for th ... more

Mixed chemicals in beauty products may harm women's hormones

18-Sep-2018 As we go about our daily lives, we are exposed to many different chemicals that could have negative effects on our hormones. These hormonal changes have been linked to several adverse health outcomes such as breast cancer and cardiovascular disease. Therefore, understanding chemicals that i ... more

Microbiome serves as sentinel for nerve gas exposure

18-Sep-2018 Exposure to banned nerve agents remains a major public health concern globally, especially because of the recent air-release of these agents in Syria. One main problem is the difficulty of determining whether an exposure has occurred. Now, a new study demonstrates that the mammalian microbi ... more

Musical sensor shows bad medicine plays false note

Inspired by a musical instrument, the simple sensor can be constructed from common materials and used to detect adulterated or counterfeit drugs

17-Sep-2018 What if a single musical note could mean the difference between life and death? A new sensor based on a 3,000 year old African musical instrument can be used to identify substances, including a poisonous chemical sometimes mistakenly added to medicines. The mbira sensor, which can be constr ... more

Sanofi to refocus two global business units

17-Sep-2018 Sanofi will change the organizational structure of two of its Global Business Units (GBU) to provide greater focus on its operations in mature markets and across emerging markets.The company will create a new Primary Care GBU that combines the product portfolios of Sanofi's existing Diabete ... more

Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106

17-Sep-2018 Galapagos NV and MorphoSys AG announced the initiation of a Phase 1 bridging study testing a subcutaneous formulation of MOR106, an investigational antibody directed against IL-17C. This bridging study is a parallel-design Phase 1 clinical trial conducted in two parts. Part 1 is a single ce ... more

Roller coaster against kidney stones, olfactory detection of flies in wine and stamps in reproductive medicine

The 2018 Ig Nobel Prize Winners

17-Sep-2018 The 2018 Ig Nobel Prizes were awarded at the 28th First Annual Ig Nobel Prize ceremony, on September 13, at Harvard's Sanders Theatre. These years prizes were awarded to: Medicine: Marc Mitchell and David Wartinger, for using roller coaster rides to try to hasten the passage of kidney ston ... more

EMBL Ventures Portfolio Company, ViraTherapeutics Acquired by Boehringer Ingelheim in EUR 210 Million Transaction

ViraTherapeutics sale marks third exit from EMBL Ventures' current fund ETF II

14-Sep-2018 EMBL Ventures announced that Boehringer Ingelheim has exercised its option to acquire EMBL Ventures' portfolio company ViraTherapeutics in a transaction with a total value of EUR 210 million (USD 245 million). The acquisition follows a collaboration and option agreement signed between ViraT ... more

All news

Researchers combine light and X-ray microscopy for comprehensive insights

11-Sep-2018 Researchers at the University of Goettingen have used a novel microscopy method. In doing so they were able to show both the illuminated and the "dark side" of the cell. The team led by Prof. Dr. Tim Salditt and Prof. Dr. Sarah Köster from the Institute of X-Ray Physics "attached" small fl ... more

DNA-based method detects trace amounts of peanut in foods

07-Sep-2018 For people with severe peanut allergies, eating even miniscule amounts of the legume can trigger anaphylaxis --- a life-threatening condition characterized by dizziness, breathing difficulties and, sometimes, loss of consciousness. Now, researchers have developed a sensitive new test to det ... more

Machine learning algorithm automatically sorts zebrafish eggs

06-Sep-2018 Zebrafish possess almost all of the same genes we humans do - and that makes their eggs the perfect model organisms for use in genetic and drug research. Previously, samples have had to be prepared manually, which is a very time-consuming task. Now, however, a clever machine learning algori ... more

Measuring the Nanoworld

Researchers establish a benchmark for accurate determination of internal dimensions within individual molecules

05-Sep-2018 A worldwide study involving 20 laboratories has established and standardized a method to measure exact distances within individual biomolecules, down to the scale of one millionth of the width of a human hair. The new method represents a major improvement of a technology called single-molec ... more

Analyzing the structure of the protein FAT10

Fundamental research for a potential cancer therapy

04-Sep-2018 FAT10 is a small protein with a huge effect. Its attachment to a target protein is a signal for its degradation. FAT10 is a marking system for degradation that seems to be inefficient. In contrast to its biological competitor, ubiquitin, which is recycled, FAT10 is degraded along with its t ... more

A bucket full of genes: pond water reveals tropical frogs

30-Aug-2018 When a frog jumps into a pond, it inevitably leaves behind traces of its genetic material. Using water samples from the Bolivian lowlands, Senckenberg scientists were now able to demonstrate that the analysis of this so-called environmental DNA allows the reliable identification of the frog ... more

Iron outperforms gadolinium as MRI contrast agent

24-Aug-2018 Rice University nanoscientists have demonstrated a method for loading iron inside nanoparticles to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast agent that is facing increased scrutiny due to potential safety concerns. "The possibility of eliminating ... more

Progress toward Personalized Medicine

Microfluidic chip for analysis of single cells

21-Aug-2018 A few little cells that are different from the rest can have a big effect. For example, individual cancer cells may be resistant to a specific chemotherapy—causing a relapse in a patient who would otherwise be cured. In the journal Angewandte Chemie, scientists have now introduced a microfl ... more

Agilent completes acquisition of Young In Scientific assets

21-Aug-2018 Agilent Technologies Inc. announced that it has completed its acquisition of the Agilent-related business from Young In Scientific Co. Ltd. and its affiliates (“YI Scientific”). YI Scientific is a distributor of analytical and scientific instruments in South Korea and a long-time distributo ... more

Titanium dioxide from sunscreen is polluting beaches

20-Aug-2018 Scientists have found that sunscreen from bathers releases significant quantities of polluting TiO2 (titanium dioxide) into the sea. This has the potential to harm marine life. This work, which comes from research on beaches in the South of France, was presented at the Goldschmidt geochemis ... more

All news on bioanalytics

How cells handle a sticky, toxic, but absolutely essential molecule

A new study shows that a protein known for its role in metabolism also helps deliver heme where it's needed

18-Sep-2018 Do you enjoy breathing air? You should spare a thought once in a while for heme, an iron-containing molecule essential to all organisms engaged in an air-breathing lifestyle. Heme molecules are most famously part of hemoglobin, the oxygen-transporting protein in blood, but they are also com ... more

BIA Separations Expands with New Upstream Processing Facility

Investment in new lab will support integrated optimisation of upstream and downstream process development

18-Sep-2018 BIA Separations announced the expansion of its services with the opening of a new upstream processing (USP) laboratory. The investment in the new facility comes in response to customer demand for services that optimise the critical interface between upstream and downstream processing for th ... more

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD

14-Sep-2018 Thermo Fisher Scientific Inc. has signed a definitive agreement with BD (Becton, Dickinson and Compan), under which Thermo Fisher will acquire BD's Advanced Bioprocessing business. This business combines a strong technical services program with a variety of peptones that enhance cell cultur ... more

WACKER Invests in Jena Biotech Site

14-Sep-2018 In Jena, the Munich-based chemical group WACKER has enhanced its production facilities for biopharmaceuticals – also known as biologics – with new equipment. Furthermore, an inspection by the Brazilian health authority ANVISA assessing the site’s quality standards was a major success. “In ... more

Evotec and Celgene enter partnership in the field of targeted protein degradation

07-Sep-2018 Evotec AG announced that Evotec and Celgene Corporation have entered into a third long-term strategic drug discovery and development partnership in the field of targeted protein degradation. In this collaboration, Evotec and Celgene will leverage Evotec's Panomics platform in order to iden ... more

Enzymicals extend its capacity in Business Development

04-Sep-2018 Dr. Rainer Wardenga is one of the co-founders of Enzymicals and support the Business Development of the company beginning September. Dr. Wardenga is biotechnologist and until the beginning of his parentalleave, he was responsible for the development of the company with focus on research and ... more

Precise, Highly Efficient Gene Repair

Researchers develop new CRISPR/Cas process using Japanese ricefish

31-Aug-2018 The molecular tool CRISPR/Cas allows introducing DNA double strand breaks into any gene of interest consequently resulting in stochastic mutations at the site of the target gene. However, precise gene repair through the application of a rescue construct suffers from limited efficiency. Rese ... more

Evotec and CHDI Foundation extend ongoing collaboration to fight Huntington's disease

31-Aug-2018 Evotec AG announced that CHDI Foundation, Inc. has extended its collaboration with Evotec through to 2023. Over this period, CHDI may fund up to 75 full-time scientists at Evotec. The collaboration was initiated in 2006 and has grown considerably over this period to fully utilise Evotec’s b ... more

Viruses Are the Better Antibiotic

Development of Novel Therapeutics Boosted With Millions of Euros

30-Aug-2018 The development of alternative therapies to combat antibiotic-resistant bacteria has attracted more than €4 million in grants and private investments for Vienna-based biotech company PhagoMed Biopharma GmbH. PhagoMed, located at the Vienna Biocenter, is focused on developing virus–(phage–) ... more

c-LEcta lays foundation for further growth and closes financing round

New CFO Thomas Pfaadt to manage and support growth

27-Aug-2018 c-LEcta has closed a financing round with Capricorn Venture Partners and the German investment company bm|t. The capital increase provides the company with growth capital as well as valuable access to an international network. c-LEcta already has a diversified shareholder structure. In addi ... more

All news on biotechnology

Microbiome serves as sentinel for nerve gas exposure

18-Sep-2018 Exposure to banned nerve agents remains a major public health concern globally, especially because of the recent air-release of these agents in Syria. One main problem is the difficulty of determining whether an exposure has occurred. Now, a new study demonstrates that the mammalian microbi ... more

For a Better Contrast

Rare earth orthoferrite LnFeO3 nanoparticles for bioimaging

06-Sep-2018 Magnetic resonance imaging (MRI) has emerged as one of the most powerful clinical imaging tools because of its superb spatial resolution and soft tissue contrast, especially when using contrast agents. In the European Journal of Inorganic Chemistry, scientists have presented a new kind of n ... more

ActLight Announces Licensing With Top Semiconductor Company

06-Sep-2018 ActLight, a Swiss technology firm known for its Dynamic PhotoDiodes (DPDs), announced that it has signed an agreement with a top semiconductor company for the integration and licensing of the DPD into their Application Specific Integrated Circuit (ASIC) for vital signs monitoring, to be use ... more

Epigenetic analysis of aggressive brain tumors

30-Aug-2018 Glioblastoma is a brain cancer with devastating prognosis. A new collaborative study by scientists from CeMM, MedUni Vienna and the Austrian Brain Tumor Registry network  demonstrates how epigenetic analysis of tumor samples collected in routine clinical practice could be used to better cla ... more

IIVS Collaborates with BASF and Givaudan to Validate a Non-animal Test for Regulatory Submissions

29-Aug-2018 The Institute for In Vitro Sciences (IIVS), with an established track record in the validation of alternatives to animal testing, is teaming up with BASF and Givaudan to validate an improved skin sensitization reactivity method to address the needs of toxicologists and regulators. Scientist ... more

Closing in on mystery surrounding dangerous blood syndromes

Genetically driven MDS enabled by gene linked to metabolism and oxygen in cells

24-Aug-2018 Scientists may be on the road to solving the mystery of a group of mostly incurable blood diseases called myelodysplastic syndromes (MDS), which cause people to have immature, malfunctioning bone marrow cells that fuel a diverse set of health problems and can lead to leukemia. MDS is linked ... more

Iron outperforms gadolinium as MRI contrast agent

24-Aug-2018 Rice University nanoscientists have demonstrated a method for loading iron inside nanoparticles to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast agent that is facing increased scrutiny due to potential safety concerns. "The possibility of eliminating ... more

Why some people with brain markers of Alzheimer’s have no dementia

22-Aug-2018 A new study from The University of Texas Medical Branch at Galveston has uncovered why some people that have brain markers of Alzheimer’s never develop the classic dementia that others do. Alzheimer’s disease, the most common form of dementia, affects more than 5 million Americans. People s ... more

'Building up' stretchable electronics to be as multipurpose as your smartphone

16-Aug-2018 By stacking and connecting layers of stretchable circuits on top of one another, engineers have developed an approach to build soft, pliable "3D stretchable electronics" that can pack a lot of functions while staying thin and small in size. As a proof of concept, a team led by the Universit ... more

Why some kidney transplants don’t work

15-Aug-2018 Scientists have discovered a ‘molecular signature’ for the allostatic load -- or ‘wear and tear’ of kidneys – which could help clinicians understand why some kidney transplants don’t work as well as expected. The University of Glasgow-led research, published today in Aging Cell and based on ... more

All news on diagnostics

LABVOLUTION AWARD to honor outstanding advances in lab technology

29-Aug-2018 There is no shortage of new initiatives, ideas and projects aimed at making laboratories run more smoothly. Keeping lab samples cool in storage while saving as much energy as possible, finding the best cleaning solution for maintaining the cleanliness of laboratory glassware, devising more ... more

Garlic ingredient from the lab bench

Total synthesis of ajoene, a biologically active component in oil extracts of garlic

24-Aug-2018 Fresh garlic extracts contain a variety of healthy organosulfur compounds, among which ajoene forms a major oil-extractable ingredient. Now, chemists in the United Kingdom have synthesized ajoene from readily available components for the first time. The results show that ajoene is accessibl ... more

Agilent completes acquisition of Young In Scientific assets

21-Aug-2018 Agilent Technologies Inc. announced that it has completed its acquisition of the Agilent-related business from Young In Scientific Co. Ltd. and its affiliates (“YI Scientific”). YI Scientific is a distributor of analytical and scientific instruments in South Korea and a long-time distributo ... more

Two new ways to fluorinated structures

Chemo-enzymatic synthesis of fluorinated antibiotics

07-Aug-2018 Fluorinated structures make up more than 20 percent of modern drugs, but benign and fast fluorination schemes are scarce. In a study scientists have now combined dynamic kinetic resolution and nucleophilic fluorination for the asymmetric synthesis of florfenicol, a veterinary antibiotic. Af ... more

Metrohm acquires B&W Tek

30-Jul-2018 Metrohm AG from Herisau, Switzerland and B&W Tek from Newark in Delaware, USA are pleased to announce the acquisition of B&W Tek’s Spectroscopy Solution Business, B&W Tek LLC, as well as several overseas subsidiaries. This acquisition contributes to the strategic growth of Metrohm enhancing ... more

Waters acquires DESI-MS technology from Prosolia

Desorption Electrospray Ionization (DESI) imaging gives deeper biological insights

25-Jul-2018 Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF. "The acquisition of DESI technology bolsters Waters' p ... more

Growing brain cancer in a dish

Organoids, that mimic the onset of brain cancer

25-Jul-2018 Brain tumors are among the most aggressive and deadly cancers and a leading cause of cancer-related death in children and young adults. Glioblastoma is a particularly aggressive form of brain tumor that is characterized by a very rapid tumor growth of glia cells – the most abundant cell ty ... more

Bachem to expand in asian markets

Subsidiary in Tokyo founded

23-Jul-2018 Bachem announces the establishment of Bachem Japan K.K., a subsidiary in Tokyo, Japan. This new local presence in Asia will strengthen project and customer support and drive further business growth in the Asian market."This is an exciting step for Bachem", comments Dr. Anne-Kathrin Stoller, ... more

New Chief Financial Officers Appointed at Carl Zeiss AG and Carl Zeiss Meditec AG

13-Jul-2018 Effective 1 October 2018, Dr. Christian Müller will become Chief Financial Officer (CFO) of Carl Zeiss AG. He will succeed Thomas Spitzenpfeil who, as previously announced, will leave the company. Müller has been CFO of the ZEISS subsidiary Carl Zeiss Meditec AG since 2009. He joined the ZE ... more

Bruker acquires Hamburg-based sensor start-up

27-Jun-2018 Thanks to its innovative, patented sensor technologies, a portfolio company in the High-Tech Gründerfond (HTGF) has reached market maturity: USA’s Bruker Corporation has taken over Hamburg startup Sierra Sensors GmbH. Sierra Sensors develop and distribute biosensor-based analytical tools an ... more

All news on lab technology

Sanofi to refocus two global business units

17-Sep-2018 Sanofi will change the organizational structure of two of its Global Business Units (GBU) to provide greater focus on its operations in mature markets and across emerging markets.The company will create a new Primary Care GBU that combines the product portfolios of Sanofi's existing Diabete ... more

Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106

17-Sep-2018 Galapagos NV and MorphoSys AG announced the initiation of a Phase 1 bridging study testing a subcutaneous formulation of MOR106, an investigational antibody directed against IL-17C. This bridging study is a parallel-design Phase 1 clinical trial conducted in two parts. Part 1 is a single ce ... more

EMBL Ventures Portfolio Company, ViraTherapeutics Acquired by Boehringer Ingelheim in EUR 210 Million Transaction

ViraTherapeutics sale marks third exit from EMBL Ventures' current fund ETF II

14-Sep-2018 EMBL Ventures announced that Boehringer Ingelheim has exercised its option to acquire EMBL Ventures' portfolio company ViraTherapeutics in a transaction with a total value of EUR 210 million (USD 245 million). The acquisition follows a collaboration and option agreement signed between ViraT ... more

Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)

14-Sep-2018 For the sixth consecutive year, Abbott has been named the leading company in its industry by the Dow Jones Sustainability Index (DJSI). Abbott is one of the 60 companies recognized for leading their respective global industries. The DJSI designation recognizes companies for responsible and ... more

Dietmar Siemssen appointed new CEO of Gerresheimer

Speaker of the Management Board and CFO Rainer Beaujean will not extend contract

07-Sep-2018 Dietmar Siemssen (55) will join the Management Board of Gerresheimer AG as Chief Executive Officer on November 1, 2018. The Supervisory Board of Gerresheimer AG approved the decision in its meeting. From 2011 to July 2018, Dietmar Siemssen was CEO of Stabilus and prior to that served for 19 ... more

LEO Pharma closes acquisition of Bayer’s prescription dermatology business in the United States

06-Sep-2018 LEO Pharma and Bayer announced the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States. Closing in all other countries is expected during the second half of 2019, subject to the fulfillment of cu ... more

Bayer completes biggest acquisition in its history

Group sales and earnings increase

05-Sep-2018 Bayer successfully completed the biggest acquisition in its history in the second quarter of 2018, while operational performance improved, even without taking into account the newly acquired Monsanto business. Sales advanced at three of the four segments on a currency- and portfolio-adjuste ... more

Medigene announces change in executive leadership team

03-Sep-2018 Medigene AG announced that the Chief Financial Officer (CFO), Dr. Thomas Taapken, will leave the Company for personal reasons and will resign from his CFO position effective August 31, 2018. His departure is not based on any disagreement with the Company's accounting principles or practices ... more

Servier finalizes acquisition of Shire’s oncology branch

03-Sep-2018 Servier announced that it has finalized the previously announced acquisition of Shire’s oncology branch after obtaining regulatory clearance. The 2.4 billion dollar transaction will enable Servier to establish a direct commercial presence in the United States and strengthen its oncology dru ... more

Evotec and Centogene sign partnership on drug discovery projects in rare genetic diseases

28-Aug-2018 Evotec AG announced that CENTOGENE AG and Evotec entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic diseases. Evotec and CENTOGENE initiated the collaboration to develop a strategic high-throughput platform f ... more

All news on pharma

TRIANNI & the German Society for Immunology (DGfI) honors outstanding young scientists.

18-Sep-2018 Every year, the German Society for Immunology awards two doctoral and three early-career prizes to young scientists who have made an outstanding contribution in the field of immunology. The award ceremony took place during the 5th European Congress of Immunology in Amsterdam. TRIANNI was ho ... more

Mixed chemicals in beauty products may harm women's hormones

18-Sep-2018 As we go about our daily lives, we are exposed to many different chemicals that could have negative effects on our hormones. These hormonal changes have been linked to several adverse health outcomes such as breast cancer and cardiovascular disease. Therefore, understanding chemicals that i ... more

Microbiome serves as sentinel for nerve gas exposure

18-Sep-2018 Exposure to banned nerve agents remains a major public health concern globally, especially because of the recent air-release of these agents in Syria. One main problem is the difficulty of determining whether an exposure has occurred. Now, a new study demonstrates that the mammalian microbi ... more

Roller coaster against kidney stones, olfactory detection of flies in wine and stamps in reproductive medicine

The 2018 Ig Nobel Prize Winners

17-Sep-2018 The 2018 Ig Nobel Prizes were awarded at the 28th First Annual Ig Nobel Prize ceremony, on September 13, at Harvard's Sanders Theatre. These years prizes were awarded to: Medicine: Marc Mitchell and David Wartinger, for using roller coaster rides to try to hasten the passage of kidney ston ... more

Cellular memory outwits pathogens

Study proves effectiveness of sequential antibiotic treatment against the pathogen Pseudomonas aeruginosa

14-Sep-2018 The World Health Organization (WHO) warns that seemingly harmless bacterial infections could develop into one of the leading causes of death in the next few years, particularly in the industrialised countries. This dramatic threat arose because, in many cases, the antibiotics that have been ... more

Science learns from its mistakes too

A mathematical model shows that even seemingly inconclusive studies speed up the gain in knowledge

14-Sep-2018 Scientific studies should always be published irrespective of their result. That is one of the conclusions of a research project conducted by the “German Centre for the Protection of Laboratory Animals” at the German Federal Institute for Risk Assessment (BfR), the results of which have now ... more

How infectious bacteria hibernate through treatment

Researchers find that bacteria may opt for persistence as well as resistance to antibiotics

13-Sep-2018 Disease-causing bacteria can develop resistance to antibiotics – which are then no longer effective in treating the infection. Yet they also have another tactic to avoid being killed off by antibiotic treatment. Some cells of the population quietly hide in a dormant state and wait for the d ... more

Special Antibodies Could Lead to HIV Vaccine

12-Sep-2018 Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the University of Zurich and the University Hospital Zurich have now shown ... more

Size matters

Size of nucleolus plays an important role in protecting cells against infection

12-Sep-2018 All cells in the body have the basic ability to protect themselves from infection, called the innate immune response. But how cells do this is not very well understood. Recently, scientists from the Max Planck Institute for Biology of Ageing and the University of Cologne, found that the siz ... more

New high-throughput screening study may open up for future Parkinson's disease therapy

12-Sep-2018 Parkinson's disease (PD) is the most common movement disorder in the world. PD patients suffer from shaking, rigidity, slowness of movement and have difficulties walking. It is neurodegenerative disease and is caused by the loss of dopaminergic neurons in the brain. Currently PD cannot be c ... more

All news on healthcare
News by department
  • Products

    Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106

    17-Sep-2018 Galapagos NV and MorphoSys AG announced the initiation of a Phase 1 bridging study testing a subcutaneous formulation of MOR106, an investigational antibody directed against IL-17C. This bridging study is a parallel-design Phase 1 clinical trial conducted in two parts. Part 1 is a single ce ... more

    LABVOLUTION AWARD to honor outstanding advances in lab technology

    29-Aug-2018 There is no shortage of new initiatives, ideas and projects aimed at making laboratories run more smoothly. Keeping lab samples cool in storage while saving as much energy as possible, finding the best cleaning solution for maintaining the cleanliness of laboratory glassware, devising more ... more

    FDA Accepts File for Cladribine Tablets as Potential Treatment for Relapsing Forms of MS

    01-Aug-2018 Merck announced that a resubmission of the New Drug Application (NDA) for cladribine tablets as a potential treatment for patients with relapsing forms of multiple sclerosis (MS) has been accepted for filing by the U.S. Food and Drug Administration (FDA). “We are delighted the FDA has accep ... more

  • Business

    Sanofi to refocus two global business units

    17-Sep-2018 Sanofi will change the organizational structure of two of its Global Business Units (GBU) to provide greater focus on its operations in mature markets and across emerging markets.The company will create a new Primary Care GBU that combines the product portfolios of Sanofi's existing Diabete ... more

    EMBL Ventures Portfolio Company, ViraTherapeutics Acquired by Boehringer Ingelheim in EUR 210 Million Transaction

    ViraTherapeutics sale marks third exit from EMBL Ventures' current fund ETF II

    14-Sep-2018 EMBL Ventures announced that Boehringer Ingelheim has exercised its option to acquire EMBL Ventures' portfolio company ViraTherapeutics in a transaction with a total value of EUR 210 million (USD 245 million). The acquisition follows a collaboration and option agreement signed between ViraT ... more

    Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD

    14-Sep-2018 Thermo Fisher Scientific Inc. has signed a definitive agreement with BD (Becton, Dickinson and Compan), under which Thermo Fisher will acquire BD's Advanced Bioprocessing business. This business combines a strong technical services program with a variety of peptones that enhance cell cultur ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    14-Nov-2013 BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    How cells handle a sticky, toxic, but absolutely essential molecule

    A new study shows that a protein known for its role in metabolism also helps deliver heme where it's needed

    18-Sep-2018 Do you enjoy breathing air? You should spare a thought once in a while for heme, an iron-containing molecule essential to all organisms engaged in an air-breathing lifestyle. Heme molecules are most famously part of hemoglobin, the oxygen-transporting protein in blood, but they are also com ... more

    TRIANNI & the German Society for Immunology (DGfI) honors outstanding young scientists.

    18-Sep-2018 Every year, the German Society for Immunology awards two doctoral and three early-career prizes to young scientists who have made an outstanding contribution in the field of immunology. The award ceremony took place during the 5th European Congress of Immunology in Amsterdam. TRIANNI was ho ... more

    Mixed chemicals in beauty products may harm women's hormones

    18-Sep-2018 As we go about our daily lives, we are exposed to many different chemicals that could have negative effects on our hormones. These hormonal changes have been linked to several adverse health outcomes such as breast cancer and cardiovascular disease. Therefore, understanding chemicals that i ... more

  • People

    Dietmar Siemssen appointed new CEO of Gerresheimer

    Speaker of the Management Board and CFO Rainer Beaujean will not extend contract

    07-Sep-2018 Dietmar Siemssen (55) will join the Management Board of Gerresheimer AG as Chief Executive Officer on November 1, 2018. The Supervisory Board of Gerresheimer AG approved the decision in its meeting. From 2011 to July 2018, Dietmar Siemssen was CEO of Stabilus and prior to that served for 19 ... more

    Enzymicals extend its capacity in Business Development

    04-Sep-2018 Dr. Rainer Wardenga is one of the co-founders of Enzymicals and support the Business Development of the company beginning September. Dr. Wardenga is biotechnologist and until the beginning of his parentalleave, he was responsible for the development of the company with focus on research and ... more

    Medigene announces change in executive leadership team

    03-Sep-2018 Medigene AG announced that the Chief Financial Officer (CFO), Dr. Thomas Taapken, will leave the Company for personal reasons and will resign from his CFO position effective August 31, 2018. His departure is not based on any disagreement with the Company's accounting principles or practices ... more

  • Finances

    Bayer completes biggest acquisition in its history

    Group sales and earnings increase

    05-Sep-2018 Bayer successfully completed the biggest acquisition in its history in the second quarter of 2018, while operational performance improved, even without taking into account the newly acquired Monsanto business. Sales advanced at three of the four segments on a currency- and portfolio-adjuste ... more

    Viruses Are the Better Antibiotic

    Development of Novel Therapeutics Boosted With Millions of Euros

    30-Aug-2018 The development of alternative therapies to combat antibiotic-resistant bacteria has attracted more than €4 million in grants and private investments for Vienna-based biotech company PhagoMed Biopharma GmbH. PhagoMed, located at the Vienna Biocenter, is focused on developing virus–(phage–) ... more

    c-LEcta lays foundation for further growth and closes financing round

    New CFO Thomas Pfaadt to manage and support growth

    27-Aug-2018 c-LEcta has closed a financing round with Capricorn Venture Partners and the German investment company bm|t. The capital increase provides the company with growth capital as well as valuable access to an international network. c-LEcta already has a diversified shareholder structure. In addi ... more

  • Cooperation

    Evotec and Celgene enter partnership in the field of targeted protein degradation

    07-Sep-2018 Evotec AG announced that Evotec and Celgene Corporation have entered into a third long-term strategic drug discovery and development partnership in the field of targeted protein degradation. In this collaboration, Evotec and Celgene will leverage Evotec's Panomics platform in order to iden ... more

    Fraunhofer IZI and Novartis Continue Collaboration with CAR-T Cell Therapy

    03-Sep-2018 Novartis and Fraunhofer IZI announced that a further agreement has been concluded between Novartis and the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig for the manufacture of the CAR (chimeric antigen receptor)-T cell therapy for patients in Europe over the next few years ... more

    Evotec and CHDI Foundation extend ongoing collaboration to fight Huntington's disease

    31-Aug-2018 Evotec AG announced that CHDI Foundation, Inc. has extended its collaboration with Evotec through to 2023. Over this period, CHDI may fund up to 75 full-time scientists at Evotec. The collaboration was initiated in 2006 and has grown considerably over this period to fully utilise Evotec’s b ... more

  • Technology

    Better Genome Editing

    Method giving complete spatiotemporal control and treads DNA lightly

    24-Aug-2018 A major obstacle to in-cell genome editing is, well, the cell itself.“Human cells don’t like to take in stuff,” explained UC Santa Barbara’s Norbert Reich, a professor in the Department of Chemistry and Biochemistry. The human cell has evolved a “trash disposal” mechanism that isolates and ... more

    Garlic ingredient from the lab bench

    Total synthesis of ajoene, a biologically active component in oil extracts of garlic

    24-Aug-2018 Fresh garlic extracts contain a variety of healthy organosulfur compounds, among which ajoene forms a major oil-extractable ingredient. Now, chemists in the United Kingdom have synthesized ajoene from readily available components for the first time. The results show that ajoene is accessibl ... more

    Closing in on mystery surrounding dangerous blood syndromes

    Genetically driven MDS enabled by gene linked to metabolism and oxygen in cells

    24-Aug-2018 Scientists may be on the road to solving the mystery of a group of mostly incurable blood diseases called myelodysplastic syndromes (MDS), which cause people to have immature, malfunctioning bone marrow cells that fuel a diverse set of health problems and can lead to leukemia. MDS is linked ... more

  • Laws

    Combined resistance to multiple antibiotics: A growing problem in the EU

    17-Nov-2017 On the occasion of the 10th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing its latest EU-wide data on antibiotic resistance, as well as its guidance on prevention and control of carbapenem-resistant Enterobacteriaceae (CRE). In ... more

    Focus on Medical Device Regulation

    BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM publish “MedTech Radar 9”

    15-Nov-2017 The EU Medical Device Regulation heralds a new era for the medical technology sector: in future, any company wishing to bring medical devices to market must face the requirements of this new regulatory framework. This implies a sizeable challenge for the many small and medium-sized enterpri ... more

    EPA to Grant Merck’s Patent Application for CRISPR Technology

    Related patent application recently awarded in Australia

    04-Aug-2017 Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technolo ... more

  • Market

    Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)

    14-Sep-2018 For the sixth consecutive year, Abbott has been named the leading company in its industry by the Dow Jones Sustainability Index (DJSI). Abbott is one of the 60 companies recognized for leading their respective global industries. The DJSI designation recognizes companies for responsible and ... more

    Bachem to expand in asian markets

    Subsidiary in Tokyo founded

    23-Jul-2018 Bachem announces the establishment of Bachem Japan K.K., a subsidiary in Tokyo, Japan. This new local presence in Asia will strengthen project and customer support and drive further business growth in the Asian market."This is an exciting step for Bachem", comments Dr. Anne-Kathrin Stoller, ... more

    Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site

    19-Jun-2018 Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare leader, Sanofi, to leading pharmaceutical contract development and manufacturing organisation, Recipharm. “Holmes Chapel brings Recipharm an ideal opportunity to ... more

  • Politics

    The starch risk to teeth

    08-Aug-2018 An examination of research on oral health, commissioned by the World Health Organisation, has indicated that for oral health we should stick to whole grain carbohydrates and avoid processed ones, especially if sweet. Food contains different types of starchy carbohydrate with varying degrees ... more

    Multinational companies continue to produce unregulated antibiotics in India

    06-Feb-2018 Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University. The research found that multinational companies continued to manufacture many unapproved formulations, despite pledging to tackle ... more

    cytena receives Dr. Rudolf-Eberle-Prize 2017

    Ministry of Economics recognizes cytena’s innovative energy

    01-Dec-2017 cytena was distinguished with the Innovation Award of Baden-Württemberg, one of the most economically powerful and competitive regions in Europe. Since 1985, the Ministry of Economics recognizes small and medium-sized enterprises for their innovative products, processes and services. The Mi ... more

  • Manufacturing

    BIA Separations Expands with New Upstream Processing Facility

    Investment in new lab will support integrated optimisation of upstream and downstream process development

    18-Sep-2018 BIA Separations announced the expansion of its services with the opening of a new upstream processing (USP) laboratory. The investment in the new facility comes in response to customer demand for services that optimise the critical interface between upstream and downstream processing for th ... more

    Tracking codes to authenticate genuine 3-D printed parts

    23-Aug-2018 The worldwide market for 3D-printed parts is a $5 billion business with a global supply chain involving the internet, email, and the cloud - creating a number of opportunities for counterfeiting and intellectual property theft. Flawed parts printed from stolen design files could produce dir ... more

    Harnessing energy from algae

    An enzyme that could help accelerate biofuel production

    21-Aug-2018 Researchers at Tokyo Institute of Technology have honed in on an enzyme belonging to the glycerol-3-phosphate acyltransferase (GPAT) family as a promising target for increasing biofuel production from the red alga Cyanidioschyzon merolae. Algae are known to store up large amounts of oils ca ... more

  • Career

    Agilent and University of Duisburg-Essen Announce Collaboration Agreement

    New Teaching and Research Center for Separation

    28-May-2018 Agilent Technologies Inc. and the University of Duisburg-Essen has formed a collaboration agreement that brings together Agilent's leading analytical technologies with the University's outstanding researchers. As part of the collaboration, Agilent will support the university with a broad ra ... more

    Systematic analysis of data from animal models reveals opportunities and limitations

    Professor Malcolm Macleod awarded the BfR’s Maria Sibylla Merian Fellowship

    18-Apr-2018 What opportunities and what limits result from the use of laboratory animals in the preclinical and clinical research? Neurologist Malcolm Macleod has dedicated himself to this topic. For his interdisciplinary research work and his contribution to improving animal welfare, he is awarded thi ... more

    Sartorius Stedim supports biotech training at U Penn

    17-Apr-2018 Sartorius Stedim Biotech andPenn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part o ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE